Is VSTM Worth Buying in 2026?

Verastem, Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-06-07

Here’s whether Verastem, Inc. (VSTM) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-5.36% over 10 days); weak 1-year return of -40.0%; 3-month momentum negative (-41.1%). Currently 67.0% off its 52-week high. Score: -6/7.

Ready to act on this? 📈 Trade on Webull

VSTM is trading below its 200-day MA ($7.27) — a key warning sign the longer-term trend is under pressure. An RSI of 32.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -40.0% compares to +24.4% for SPY (trailed the market by 64.3%). The current 67.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $6,003 today
vs. S&P 500 (SPY) — same period trailed market by 64.3%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($7.27)
Above 50-day MA ($5.15)
RSI(14) neutral zone (30–70) — currently 32.8
Positive return (-40.0%)
!Within 10% of period high (−67.0%)
Period Range $3.71
$3.58 $11.25
RSI (14) 32.8
0 · OversoldOverbought · 100

Key Metrics

Price$3.71
Period Return-40.0%
Period High$11.25
Period Low$3.58
Drawdown−67.0%
MA-50$5.15
MA-200$7.27
RSI (14)32.8
Avg Volume (30d)2.4M
vs. SPYtrailed by 64.3%
Return Rank#1022 of 1245

Trade VSTM

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers